Cytomark

Cytomark

Cell Stabilisation Reagents for use in Flow Cytometry

MENUMENU
  • Home
  • About
    • History
    • Meet the Team
    • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
    • Blood Collection Tubes
    • Cerebrospinal Fluid
    • Circulating Tumour Cells
    • Sample Storage
  • Flow Cytometry Essentials
  • Custom Products
  • Resources
    • News Feed
    • Bibliography
    • FAQ
    • Product Information
    • Marketing Resources
    • Safety and Quality
  • Contact Us
    • Distributors
    • Subscribe to the Cytomark Newsletter
    • Privacy Policy
Cytomark

Cytomark

Cell Stabilisation Reagents for use in Flow Cytometry

MENUMENU
  • Home
  • About
    • History
    • Meet the Team
    • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
    • Blood Collection Tubes
    • Cerebrospinal Fluid
    • Circulating Tumour Cells
    • Sample Storage
  • Flow Cytometry Essentials
  • Custom Products
  • Resources
    • News Feed
    • Bibliography
    • FAQ
    • Product Information
    • Marketing Resources
    • Safety and Quality
  • Contact Us
    • Distributors
    • Subscribe to the Cytomark Newsletter
    • Privacy Policy

Tag: Cerebrospinal Fluid

1st February 2022 Cytomark

White Paper: Evaluation of TransFix/EDTA CSF Sample Storage Tubes compared to alternative preservation methods

Cytomark are pleased to announce the launch of their TransFix/EDTA CSF Sample Storage Tubes as CE marked in vitro diagnostic devices. Below we present finding on the effect of TransFix on cerebrospinal fluid samples, when compared to untreated samples, and …

Read More
23rd October 2019 Cytomark

TransFix Stabilisation of Malignant Haematological Cells in Cerebrospinal Fluid

Flow Cytometric Analysis of Cerebrospinal Fluid (CSF) Invasion of leucocytes into cerebrospinal fluid has grave prognostic significance and requires important therapeutic decisions including the administration of intrathecal chemotherapy. Leptomeningeal localisation is conventionally diagnosed by cytomorphological analysis through identification of malignant …

Read More
5th December 2017 Cytomark

Validating the use of TransFix to stabilise cerebrospinal fluid (CSF) for flow cytometry immunophenotyping of haematological malignancies

Cytomark, a division of Caltag Medsystems, recently presented a scientific poster at the ICCS2017 conference in collaboration with Bristol Royal Infirmary (Bristol, UK) “Validating the use of TransFix to stabilise cerebrospinal fluid (CSF) for flow cytometry immunophenotyping of haematological malignancies” …

Read More

Categories

  • CSF
  • CTC
  • Featured
  • Latest News
  • Other
  • SST
  • TFB
  • TVT

Recent News

  • White Paper: Evaluation of TransFix/EDTA CSF Sample Storage Tubes compared to alternative preservation methods
  • Preservation of CD34+ Stem Cells and Precursors with TransFix
  • Stabilisation of T-Cell Activation Markers
  • Stabilisation of Circulating Endothelial Progenitor Cells
  • TransFix Stabilisation of Blood Collected on Heparin Anticoagulants

Cytomark
a division of Caltag Medsystems

Caltag Medsytems

Quick Links:

  • News Feed
  • Quality and Regulatory Assurance
  • TransFix®
  • Sample Stabilisation
  • Product Information
  • Distributors
  • FAQ

Cytomark Ltd.

Whiteleaf Business Centre
11 Little Balmer
Buckingham
MK18 1TF
United Kingdom

+44 (0) 1280 827460

support@cytomark.co.uk

Subscribe to our Newsletter

Contact Us

ISO13485:2016

© 2015-2025 Cytomark Ltd.
Your Privacy
HTML Sitemap   XML Sitemap
Webmaster: AnnWebCom
Cytomark Ltd. is registered in the UK, No. 11863469. Registered Office: Whiteleaf Business Centre, 11 Little Balmer, Buckingham, MK18 1TF, UK. VAT Reg. No. GB 317 0847 08
Scroll